# Neuroprotective Effects of Xenon Treatment in Patients with Cerebral Infarction

> **NCT05335109** · PHASE3 · COMPLETED · sponsor: **Negovsky Reanimatology Research Institute** · enrollment: 40 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Xenon
- **DRUG:** Oxygen 30 %

## Key facts

- **NCT ID:** NCT05335109
- **Lead sponsor:** Negovsky Reanimatology Research Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2024-01-15
- **Final completion:** 2024-01-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05335109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05335109, "Neuroprotective Effects of Xenon Treatment in Patients with Cerebral Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05335109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*